Anaplastic Astrocytoma Global Clinical Trials Review, H1, 2012
Anaplastic Astrocytoma Global Clinical Trials Review, H1, 2012
Summary
GlobalData's clinical trial report, “Anaplastic Astrocytoma Global Clinical Trials Review, H1, 2012" provides data on the Anaplastic Astrocytoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Anaplastic Astrocytoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Anaplastic Astrocytoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
Summary
GlobalData's clinical trial report, “Anaplastic Astrocytoma Global Clinical Trials Review, H1, 2012" provides data on the Anaplastic Astrocytoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Anaplastic Astrocytoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Anaplastic Astrocytoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)
- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Contents
IntroductionAnaplastic Astrocytoma
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Countries Contributing to Clinical Trials in Middle East and Africa
Top Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by BRIC Nations
Clinical Trials by G7 Nations
Clinical Trials in G7 Nations by Trial Status
Clinical Trials by E7 Nations
Clinical Trials in E7 Nations by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Unaccomplished Trials of Anaplastic Astrocytoma
Subjects Recruited Over a Period of Time
Prominent Sponsors
Top Companies Participating in Anaplastic Astrocytoma Therapeutics Clinical Trials
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
INSYS Therapeutics, Inc.
Clinical Trial Overview of INSYS Therapeutics, Inc.
Antisense Pharma GmbH
Clinical Trial Overview of Antisense Pharma GmbH
Tocagen Inc.
Clinical Trial Overview of Tocagen Inc.
Boneca Corporation
Clinical Trial Overview of Boneca Corporation
Advantagene, Inc.
Clinical Trial Overview of Advantagene, Inc.
Teva Pharmaceuticals USA, Inc.
Clinical Trial Overview of Teva Pharmaceuticals USA, Inc.
Light Sciences Oncology, Inc.
Clinical Trial Overview of Light Sciences Oncology, Inc.
Grifols, S.A.
Clinical Trial Overview of Grifols, S.A.
Merck & Co., Inc.
Clinical Trial Overview of Merck & Co., Inc.
Amgen Inc.
Clinical Trial Overview of Amgen Inc.
Biogen Idec Inc.
Clinical Trial Overview of Biogen Idec Inc.
Clinical Trial Overview of Top Universities / Institutes / Hospitals
Weill Cornell Medical College
Clinical Trial Overview of Weill Cornell Medical College
Duke University
Clinical Trial Overview of Duke University
City of Hope National Medical Center
Clinical Trial Overview of City of Hope National Medical Center
University of California, San Francisco
Clinical Trial Overview of University of California, San Francisco
H. Lee Moffitt Cancer Center & Research Institute
Clinical Trial Overview of H. Lee Moffitt Cancer Center & Research Institute
University of California, Los Angeles
Clinical Trial Overview of University of California, Los Angeles
Wake Forest University
Clinical Trial Overview of Wake Forest University
Fred Hutchinson Cancer Research Center
Clinical Trial Overview of Fred Hutchinson Cancer Research Center
European Organization for Research and Treatment of Cancer
Clinical Trial Overview of European Organization for Research and Treatment of Cancer
University of Heidelberg
Clinical Trial Overview of University of Heidelberg
Memorial Sloan Kettering Cancer Center
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
Dartmouth-Hitchcock Medical Center
Clinical Trial Overview of Dartmouth-Hitchcock Medical Center
Northwestern University
Clinical Trial Overview of Northwestern University
University of Colorado
Clinical Trial Overview of University of Colorado
Haukeland University Hospital
Clinical Trial Overview of Haukeland University Hospital
Case Comprehensive Cancer Center
Clinical Trial Overview of Case Comprehensive Cancer Center
Dana-Farber Cancer Institute
Clinical Trial Overview of Dana-Farber Cancer Institute
Roswell Park Cancer Institute
Clinical Trial Overview of Roswell Park Cancer Institute
Hopitaux Universitaires de Geneve
Clinical Trial Overview of Hopitaux Universitaires de Geneve
Drexel University
Clinical Trial Overview of Drexel University
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source
LIST OF TABLES
Anaplastic Astrocytoma Therapeutics Market, Global, Clinical Trials by Zone, 2012*
Anaplastic Astrocytoma Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
Anaplastic Astrocytoma Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
Anaplastic Astrocytoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2012*
Anaplastic Astrocytoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2012*
Anaplastic Astrocytoma Therapeutics Clinical Trials, North America, Top Countries, 2012*
Anaplastic Astrocytoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012*
Anaplastic Astrocytoma Therapeutics Clinical Trials, Central and South America, Top Countries, 2012*
Anaplastic Astrocytoma Therapeutics Clinical Trials, BRIC Countries, 2012*
Anaplastic Astrocytoma Therapeutics Clinical Trials, G7 Countries, 2012*
Anaplastic Astrocytoma Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012*
Anaplastic Astrocytoma Therapeutics Clinical Trials, E7 Countries, 2012*
Anaplastic Astrocytoma Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012*
Anaplastic Astrocytoma Therapeutics Market, Global, Clinical Trials by Phase, 2012*
Anaplastic Astrocytoma Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012*
Anaplastic Astrocytoma Therapeutics Market, Global, Clinical Trials by Trial Status, 2012*
Anaplastic Astrocytoma Therapeutics Market, Global, Suspended Clinical Trials, 2012*
Anaplastic Astrocytoma Therapeutics Market, Global, Withdrawn Clinical Trials, 2012*
Anaplastic Astrocytoma Therapeutics Market, Global, Terminated Clinical Trials, 2012*
Anaplastic Astrocytoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Anaplastic Astrocytoma Therapeutics Clinical Trials, Global, Key Sponsors, 2012*
Anaplastic Astrocytoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012*
Anaplastic Astrocytoma Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012*
Anaplastic Astrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by INSYS Therapeutics, Inc., 2012*
Anaplastic Astrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Antisense Pharma GmbH, 2012*
Anaplastic Astrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Tocagen Inc., 2012*
Anaplastic Astrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Boneca Corporation, 2012*
Anaplastic Astrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Advantagene, Inc., 2012*
Anaplastic Astrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Teva Pharmaceuticals USA, Inc., 2012*
Anaplastic Astrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Light Sciences Oncology, Inc., 2012*
Anaplastic Astrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Grifols, S.A., 2012*
Anaplastic Astrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2012*
Anaplastic Astrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2012*
Anaplastic Astrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Biogen Idec Inc., 2012*
Anaplastic Astrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Weill Cornell Medical College, 2012*
Anaplastic Astrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2012*
Anaplastic Astrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by City of Hope National Medical Center, 2012*
Anaplastic Astrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2012*
Anaplastic Astrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by H. Lee Moffitt Cancer Center & Research Institute, 2012*
Anaplastic Astrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Los Angeles, 2012*
Anaplastic Astrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Wake Forest University, 2012*
Anaplastic Astrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2012*
Anaplastic Astrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2012*
Anaplastic Astrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Heidelberg, 2012*
Anaplastic Astrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2012*
Anaplastic Astrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Dartmouth-Hitchcock Medical Center, 2012*
Anaplastic Astrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2012*
Anaplastic Astrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Colorado, 2012*
Anaplastic Astrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Haukeland University Hospital, 2012*
Anaplastic Astrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2012*
Anaplastic Astrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Dana-Farber Cancer Institute, 2012*
Anaplastic Astrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Roswell Park Cancer Institute, 2012*
Anaplastic Astrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Hopitaux Universitaires de Geneve, 2012*
Anaplastic Astrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Drexel University, 2012*
LIST OF FIGURES
Anaplastic Astrocytoma Therapeutics Market, Global, Clinical Trials by Zone (%), 2012*
Anaplastic Astrocytoma Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
Anaplastic Astrocytoma Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
Anaplastic Astrocytoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2012*
Anaplastic Astrocytoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012*
Anaplastic Astrocytoma Therapeutics Clinical Trials, North America, Top Countries (%), 2012*
Anaplastic Astrocytoma Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2012*
Anaplastic Astrocytoma Therapeutics Clinical Trials, BRIC Countries (%), 2012*
Anaplastic Astrocytoma Therapeutics Clinical Trials, G7 Countries (%), 2012*
Anaplastic Astrocytoma Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012*
Anaplastic Astrocytoma Therapeutics Clinical Trials, E7 Countries (%), 2012*
Anaplastic Astrocytoma Therapeutics Market, Global, Clinical Trials by Phase (%), 2012*
Anaplastic Astrocytoma Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012*
Anaplastic Astrocytoma Therapeutics Market, Global, Clinical Trials by Trial Status, 2012*
Anaplastic Astrocytoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Anaplastic Astrocytoma Therapeutics Clinical Trials, Global, Key Sponsors, 2012*
Anaplastic Astrocytoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012*
Anaplastic Astrocytoma Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012*
GlobalData Methodology Skip to top